December 15th, 2015

The TXG Paradox: Analysts Bullish But Forecast -5.77% Fall

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with 10x Genomics Inc (TXG). The average 12-month price target for TXG — averaging the work of 7 analysts — reveals an average price target of $114.86/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.